Does Pioglitazone And Glimepiride Interact with Insulin Human?
Pioglitazone And Glimepiride and Insulin Human have a moderate drug interaction according to U.S. FDA drug labeling data. May increase glucose-lowering effect of glimepiride, increasing susceptibility to hypoglycemia. Close monitoring required. The mechanism involves additive glucose-lowering effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Pioglitazone And Glimepiride Class
- Sulfonylurea
- Insulin Human Class
- Insulin
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Pioglitazone And Glimepiride and Insulin Human occurs because additive glucose-lowering effect. Clinically, this means may increase glucose-lowering effect of glimepiride, increasing susceptibility to hypoglycemia. close monitoring required. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Pioglitazone And Glimepiride and your doctor is considering prescribing Insulin Human (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider